InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) Shares Sold by White Pine Capital LLC

White Pine Capital LLC decreased its holdings in InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) by 3.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 149,302 shares of the medical instruments supplier’s stock after selling 5,079 shares during the quarter. White Pine Capital LLC owned about 0.70% of InfuSystem worth $1,574,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Barclays PLC acquired a new stake in InfuSystem during the 2nd quarter worth about $35,000. WINTON GROUP Ltd acquired a new stake in InfuSystem during the 3rd quarter worth about $101,000. Citigroup Inc. lifted its position in InfuSystem by 124.1% during the 3rd quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier’s stock worth $488,000 after acquiring an additional 28,038 shares during the period. First Eagle Investment Management LLC lifted its position in InfuSystem by 29.6% during the 3rd quarter. First Eagle Investment Management LLC now owns 468,400 shares of the medical instruments supplier’s stock worth $4,515,000 after acquiring an additional 107,001 shares during the period. Finally, Heartland Advisors Inc. lifted its position in InfuSystem by 17.6% during the 3rd quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier’s stock worth $4,820,000 after acquiring an additional 75,000 shares during the period. Institutional investors and hedge funds own 71.13% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com upgraded InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, April 17th.

InfuSystem Trading Up 6.7 %

Shares of InfuSystem stock traded up $0.51 on Friday, hitting $8.12. 27,842 shares of the company were exchanged, compared to its average volume of 48,498. The stock has a market cap of $172.63 million, a P/E ratio of 270.76 and a beta of 1.24. InfuSystem Holdings, Inc. has a 1-year low of $7.57 and a 1-year high of $11.44. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.95 and a quick ratio of 1.54.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.